US FDA Adcomm Reform: Does Listening Session Suggest No Major Near-Term Changes?

29 Apr 2024

The agency seeks feedback at a 13 June virtual hearing on three general topics related to advisory committees: panel composition, barriers to service for Special Government Employees, and public perception and understanding of the adcomm process.

The US Food and Drug Administration’s initiative to optimize the advisory committee process is going out for public comment, suggesting that despite ongoing reform efforts, major changes may not be implemented for some time.

The FDA will hold a virtual listening session on 13 June to solicit feedback on the agency’s use and processes...